Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature. 2009

Klaus H Metzeler, and Stefan Boeck, and Birgit Christ, and Andreas Hausmann, and Hans-Joachim Stemmler, and Klaus G Parhofer, and Helmut Ostermann, and Wolfgang Hiddemann, and Jan Braess

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008942 Mitoxantrone An anthracenedione-derived antineoplastic agent. Mitozantrone,CL-232325,DHAQ,Mitoxantrone Acetate,Mitoxantrone Hydrochloride,Mitroxone,NSC-279836,NSC-287836,NSC-299195,NSC-301739,NSC-301739D,Novantron,Novantrone,Onkotrone,Pralifan,Ralenova,Acetate, Mitoxantrone,CL 232325,CL232325,Hydrochloride, Mitoxantrone,NSC 279836,NSC 287836,NSC 299195,NSC 301739,NSC 301739D,NSC279836,NSC287836,NSC299195,NSC301739,NSC301739D
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090243 Nucleophosmin Predominantly localized in the CELL NUCLEOLUS, involved in diverse cellular processes such as ribosome biogenesis, cytoplasmic-nuclear trafficking, centrosome duplication, and regulation of p53. NO38 Protein,Nucleolar Phosphoprotein B23,Nucleolar Protein B23,Nucleophosmid,Numatrin,Phosphoprotein B23, Nucleolus,Protein B23,B23, Nucleolar Phosphoprotein,B23, Nucleolar Protein,B23, Nucleolus Phosphoprotein,B23, Protein,Nucleolus Phosphoprotein B23,Phosphoprotein B23, Nucleolar,Protein B23, Nucleolar,Protein, NO38
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute

Related Publications

Klaus H Metzeler, and Stefan Boeck, and Birgit Christ, and Andreas Hausmann, and Hans-Joachim Stemmler, and Klaus G Parhofer, and Helmut Ostermann, and Wolfgang Hiddemann, and Jan Braess
January 2020, Case reports in hematology,
Klaus H Metzeler, and Stefan Boeck, and Birgit Christ, and Andreas Hausmann, and Hans-Joachim Stemmler, and Klaus G Parhofer, and Helmut Ostermann, and Wolfgang Hiddemann, and Jan Braess
January 2021, Hematology, transfusion and cell therapy,
Klaus H Metzeler, and Stefan Boeck, and Birgit Christ, and Andreas Hausmann, and Hans-Joachim Stemmler, and Klaus G Parhofer, and Helmut Ostermann, and Wolfgang Hiddemann, and Jan Braess
May 1989, The American journal of medicine,
Klaus H Metzeler, and Stefan Boeck, and Birgit Christ, and Andreas Hausmann, and Hans-Joachim Stemmler, and Klaus G Parhofer, and Helmut Ostermann, and Wolfgang Hiddemann, and Jan Braess
December 2016, Jornal brasileiro de nefrologia,
Klaus H Metzeler, and Stefan Boeck, and Birgit Christ, and Andreas Hausmann, and Hans-Joachim Stemmler, and Klaus G Parhofer, and Helmut Ostermann, and Wolfgang Hiddemann, and Jan Braess
August 2002, American journal of hematology,
Klaus H Metzeler, and Stefan Boeck, and Birgit Christ, and Andreas Hausmann, and Hans-Joachim Stemmler, and Klaus G Parhofer, and Helmut Ostermann, and Wolfgang Hiddemann, and Jan Braess
April 2020, Journal of hematology,
Klaus H Metzeler, and Stefan Boeck, and Birgit Christ, and Andreas Hausmann, and Hans-Joachim Stemmler, and Klaus G Parhofer, and Helmut Ostermann, and Wolfgang Hiddemann, and Jan Braess
February 2020, JAAD case reports,
Klaus H Metzeler, and Stefan Boeck, and Birgit Christ, and Andreas Hausmann, and Hans-Joachim Stemmler, and Klaus G Parhofer, and Helmut Ostermann, and Wolfgang Hiddemann, and Jan Braess
March 2018, The New England journal of medicine,
Klaus H Metzeler, and Stefan Boeck, and Birgit Christ, and Andreas Hausmann, and Hans-Joachim Stemmler, and Klaus G Parhofer, and Helmut Ostermann, and Wolfgang Hiddemann, and Jan Braess
November 1988, The American journal of medicine,
Klaus H Metzeler, and Stefan Boeck, and Birgit Christ, and Andreas Hausmann, and Hans-Joachim Stemmler, and Klaus G Parhofer, and Helmut Ostermann, and Wolfgang Hiddemann, and Jan Braess
November 2005, Leukemia,
Copied contents to your clipboard!